I've had several questions on the timeframe for developing Golden Promise with TriR. At this time, we are regenerating plants from bombarded embryos that survived selection. We will be testing these plants for the presence and expression of the transgenes this summer, and should have plants available for the breeders for fall crosses. One problem with these constructs is proprietary rights. The TriR gene is public domain, but the promoter (maize ubiquitin) is patented. Also, the selectable gene, bar, also is patented. There may be some difficulty in releasing cultivars containing these patented parts. Has anyone talked with the owners of these genes about licensing?
Olin, Peggy Lemaux has developed two improved culture/transformation systems, one which is proprietary with Coors. The other one is public, and Peggy would probably be willing to train Gary's student in that one.
Lynn Dahleen